Rapid on-site genetic sequencing could help curb antimicrobial-resistant outbreaks, says MHRA Researchers found that rapid on-site genetic sequencing detects bacterial infections within two days, which is “significantly faster“ than traditional methods.…
Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…
Pharmacogenomics trial expands across England Programme co-ordinators are aiming to recruit a further 1,450 people to the second phase of the PROGRESS trial, which is the first in the UK to introduce genetic testing before prescribing in primary care.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…
One-quarter of patients in pharmacogenomics trial have had prescriptions changed Around 25% of the 400 participants of the 'Progress programme' have been advised to change their prescription following genetic testing.…
Proposed National Pharmaceutical Agency on hold, says Scottish government Exclusive: The Scottish government has confirmed that the scoping phase in the development of a National Pharmaceutical Agency was paused before completion, with no next steps planned.…
More than 2,000 patients tested in UK’s first routine genotyping project for clopidogrel prescribing Exclusive: The genotyping project at NHS Tayside identified 2,300 patients, 29% of whom emerged as ‘poor’ or ‘intermediate’ CYP2C19-clopidogrel metabolisers.…
Lessons from testing 2,300 patients at the UK’s first CYP2C19 genotyping system Specialist clinical pharmacist Alex Matos explains what his team has learned in the two years since setting up the NHS Tayside project to genotype acute stroke patients with an indication for clopidogrel.…
Best practice principles for inclusive care of transgender and non-binary patients How pharmacists can best contribute to the care of transgender and non-binary patients, outlining additional considerations to ensure equitable care of this patient group.…
PJ view: Current testing for genetic variants risks undoing years of progress on health inequalities It is crucial that the NHS prioritises health equity as pharmacogenomic testing gains traction in day-to-day UK healthcare.…